Frentizole|cas 26130-02-9|DC Chemicals

Frentizole|cas 26130-02-9|DC Chemicals

Frentizole, an FDA-approved immunosuppressive drug, is a novel inhibitor of the Aβ-ABAD interaction.

IC50 value:

Target: Aβ-ABAD interaction

Product Name: Frentizole|Cat No: DC9344|Cas: 26130-02-9|Molecule Formular: C15H13N3O2S|Molecule Weight: 299.3476|Other names: Frentizole

Frentizole, an FDA-approved immunosuppressive drug, is a novel inhibitor of the Aβ-ABAD interaction.

For research only, not for human use!